Efficacy and safety of high-dose gentamicin re-dosing in ICU patients receiving haemodialysis

J Antimicrob Chemother. 2015 Jan;70(1):308-10. doi: 10.1093/jac/dku369. Epub 2014 Sep 19.

Authors

Nicolas Venisse¹, Antoine Dupuis², Julie Badin³, René Robert⁴, Michel Pinsard³, Anne Veinstein³

Affiliations

¹ Pharmacokinetics Department, University Hospital of Poitiers, Poitiers, France nicolas.venisse@chu-poitiers.fr.
² Pharmacy Department and UMR CNRS 7285, University Hospital of Poitiers, Poitiers, France.
³ Medical Intensive Care Unit, University Hospital of Poitiers, Poitiers, France.
⁴ Medical Intensive Care Unit, University Hospital of Poitiers, Poitiers, France INSERM U927, University of Poitiers, Poitiers, France.

PMID: 25239463
DOI: 10.1093/jac/dku369

No abstract available

Keywords: acute kidney injury; pharmacodynamics; pharmacokinetics.

Publication types

Letter
Observational Study

MeSH terms

Acute Kidney Injury / therapy
Adult
Aged
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / pharmacokinetics
Gentamicins / administration & dosage*
Gentamicins / adverse effects*
Gentamicins / pharmacokinetics
Humans
Intensive Care Units
Male
Middle Aged
Prospective Studies
Renal Dialysis*

Substances

Anti-Bacterial Agents
Gentamicins